Blockbuster weight loss drugs have been arguably the biggest health story of the last several years — and there are no signs ...

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price ...

We’re firmly in the “buyer beware” era of obesity drugs. And unfortunately, it seems like we’re going to be stuck here for a ...

The lowest dose of Novo's Wegovy used to start new patients remains listed as in shortage. Patrik Jonsson, Lilly's president of cardiometabolic health, said in an interview that the vials launch ...

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

The demand for weight loss medications are on the rise, and now, “natural” GLP-1s are being marketed to help you lose weight.

Eli Lilly surged 58% in 2024, driven by weight-loss drugs and strong earnings. The technical chart shows consolidation. See ...

The new 2.5 milligram (mg) and 5 mg weekly dose vials differ from the standard preloaded injector pens that are used to administer Zepbound (tirzepatide) and competitors such as Wegovy (semaglutide).

The company shipped some 750 vials of testosterone to customers who had instead ordered ... struggled to meet demand after ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable ...